TY - JOUR
T1 - Transdermal auricular vagus stimulation for the treatment of postural tachycardia syndrome
AU - Diedrich, André
AU - Urechie, Vasile
AU - Shiffer, Dana
AU - Rigo, Stefano
AU - Minonzio, Maura
AU - Cairo, Beatrice
AU - Smith, Emily C
AU - Okamoto, Luis E
AU - Barbic, Franca
AU - Bisoglio, Andrea
AU - Porta, Alberto
AU - Biaggioni, Italo
AU - Furlan, Raffaello
N1 - Copyright © 2021 Elsevier B.V. All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - Postural Tachycardia Syndrome (POTS) is a chronic disorder characterized by symptoms of orthostatic intolerance such as fatigue, lightheadedness, dizziness, palpitations, dyspnea, chest discomfort and remarkable tachycardia upon standing. Non-invasive transdermal vagal stimulators have been applied for the treatment of epilepsy, anxiety, depression, headache, and chronic pain syndromes. Anti-inflammatory and immunomodulating effects after transdermal vagal stimulation raised interest for applications in other diseases. Patients with sympathetic overactivity, reduced cardiac vagal drive and presence of systemic inflammation like POTS may benefit from tVNS. This article will address crucial methodological aspects of tVNS and provide preliminary results of its acute and chronic use in POTS, with regards to its potential effectiveness on autonomic symptoms reduction and heart rate modulation.
AB - Postural Tachycardia Syndrome (POTS) is a chronic disorder characterized by symptoms of orthostatic intolerance such as fatigue, lightheadedness, dizziness, palpitations, dyspnea, chest discomfort and remarkable tachycardia upon standing. Non-invasive transdermal vagal stimulators have been applied for the treatment of epilepsy, anxiety, depression, headache, and chronic pain syndromes. Anti-inflammatory and immunomodulating effects after transdermal vagal stimulation raised interest for applications in other diseases. Patients with sympathetic overactivity, reduced cardiac vagal drive and presence of systemic inflammation like POTS may benefit from tVNS. This article will address crucial methodological aspects of tVNS and provide preliminary results of its acute and chronic use in POTS, with regards to its potential effectiveness on autonomic symptoms reduction and heart rate modulation.
KW - Fatigue Syndrome, Chronic
KW - Heart Rate
KW - Humans
KW - Orthostatic Intolerance
KW - Postural Orthostatic Tachycardia Syndrome/therapy
KW - Tachycardia
U2 - 10.1016/j.autneu.2021.102886
DO - 10.1016/j.autneu.2021.102886
M3 - Article
C2 - 34634682
SN - 1566-0702
VL - 236
SP - 102886
JO - Autonomic Neuroscience: Basic and Clinical
JF - Autonomic Neuroscience: Basic and Clinical
ER -